1.      Aronson MD, Komaroff AL, Pass TM, et al. Heterophil antibody in adults with sore throat: frequency and clinical presentation. Ann Intern Med 1982; 96(4):505-508. doi:10.7326/0003-4819-96-4-505 

2.      Aronson MD. Infectious mononucleosis. UpToDate. 2025. https://www.uptodate.com/contents/infectious-mononucleosis. Erişim tarihi: Eylül 2025.

3.      Auwaerter PG. Infectious mononucleosis in middle age. JAMA 1999; 281(5):454-459. doi:10.1001/jama.281.5.454

4.      Balfour HH Jr, Odumade OA, Schmeling DO, et al. Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis 2013; 207(1):80-88. doi:10.1093/infdis/jis646

5.      Bergsten E, Horne A, Aricó M, et al. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood 2017(25); 130:2728-2738. doi:10.1182/blood-2017-06-788349

6.      Biten AA. Herpes virüsler: Epidemiyoloji. Kurtoğlu MG, Biten AA, editörler. Human Herpes Virüsler. 1. Baskı. Ankara: Türkiye Klinikleri; 2023. p.18-22.

7.      Bruu AL, Hjetland R, Holter E, et al. Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin Diagn Lab Immunol 2000; 7(3):451-456. doi:10.1128/CDLI.7.3.451-456.2000

8.      Carter RL, Penman HG (Eds). Infectious Mononucleosis. Blackwell Scientific Publications, 1969. p.47.

9.      Damania B, Kenney SC, Raab-Traub N. Epstein-Barr virus: Biology and clinical disease. Cell 2022; 185(20):3652-3670. doi:10.1016/j.cell.2022.08.026

10.  Dunmire SK, Hogquist KA, Balfour HH. Infectious Mononucleosis. Curr Top Microbiol Immunol 2015; 390(Pt 1):211-240. doi:10.1007/978-3-319-22822-8_9

11.  Evans AS, Niederman JC, Cenabre LC, et al. A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody. J Infect Dis 1975; 132(5):546-554. doi:10.1093/infdis/132.5.546

12.  Evans AS, Niederman JC. Epstein-Barr virus. In: Viral Infections of Humans: Epidemiology and Control, 3rd ed, Evans AS (Ed), Plenum Medical Book Company, 1989. p.265.

13.  Evans AS. Infectious mononucleosis and related syndromes. Am J Med Sci 1978; 276(3):325-339. doi:10.1097/00000441-197811000-00010

14.  Fafi-Kremer S, Morand P, Brion JP, et al. Long-term shedding of infectious epstein-barr virus after infectious mononucleosis. J Infect Dis 2005; 191(6):985-989. doi:10.1086/428097

15.  Grotto I, Mimouni D, Huerta M, et al. Clinical and laboratory presentation of EBV positive infectious mononucleosis in young adults. Epidemiol Infect. 2003;131(1):683-689. doi:10.1017/s0950268803008550

16.  Henter JI. Hemophagocytic Lymphohistiocytosis. N Engl J Med 2025; 392(6):584-596. doi:10.1056/NEJMra2314005

17.  Hoagland, RJ. The clinical manifestations of infectious mononucleosis: a report of two hundred cases. Am. J. Med. Sci. 1960; 240:55-63.

18.  Hoover K, Higginbotham K. Epstein-Barr Virus. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559285/

19.  Horwitz CA, Henle W, Henle G, et al. Clinical and laboratory evaluation of infants and children with Epstein-Barr virus-induced infectious mononucleosis: report of 32 patients (aged 10-48 months). Blood 1981; 57:933-938.

20.  Kusuhara K, Takabayashi A, Ueda K, et al. Breast milk is not a significant source for early Epstein-Barr virus or human herpesvirus 6 infection in infants: a seroepidemiologic study in 2 endemic areas of human T-cell lymphotropic virus type I in Japan. Microbiol Immunol 1997; 41(4):309-312. doi:10.1111/j.1348-0421.1997.tb01206.x

21.  Lupo J, Truffot A, Andreani J, et al. Virological Markers in Epstein-Barr Virus-Associated Diseases. Viruses 2023; 15(3):656. doi:10.3390/v15030656

22.  Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med 2010; 362(21):1993-2000. doi:10.1056/NEJMcp1001116

23.  Monem SA, O'Connor PF, O'Leary TG. Peritonsillar abscess and infectious mononucleosis: an association or a different presentation of the same condition. Ir Med J 1999; 92(2):278-280.

24.  Odumade OA, Hogquist KA, Balfour HH Jr. Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev 2011; 24(1):193-209. doi:10.1128/CMR.00044-10

25.  Rea TD, Russo JE, Katon W, et al. Prospective study of the natural history of infectious mononucleosis caused by Epstein-Barr virus. J Am Board Fam Pract 2001; 14(4):234-242.

26.  Shi J, Chu C, Yu M, et al. Clinical warning of hemophagocytic syndrome caused by Epstein-Barr virus. Ital J Pediatr 2021; 47(1):3. doi:10.1186/s13052-020-00949-7

27.  Sullivan JL. Clinical manifestations and treatment of Epstein-Barr virus infection. UpToDate. 2025. https://www.uptodate.com/contents/clinical-manifestations-and-treatment-of-epstein-barr-virus-infection. Erişim tarihi: Eylül 2025.

28.  Womack J, Jimenez M. Common questions about infectious mononucleosis. Am Fam Physician 2015; 91(6):372-376.